Fundz

Metabolize secures $3.2 million in seed financing to enhance metabolic health solutions. The funding, led by Astanor, will support the launch of NATLEAN and expand its product portfolio.

PRIVATEOct 15, 2026

Amount Raised

$3.2 Million

Round Type

Seed

San FranciscoBiotechnologyHealth Care

Investors

SosvLongGame VentureAstanorMaia Ventures

Description

Metabolize, a science-first consumer health company, announced the completion of its $3.2 million seed financing. The investment, led by Astanor, will accelerate commercialization of its Precision Metabolite™ Technology. Funds will also support continued development and manufacturing of its metabolic health products. Founded in 2024, Metabolize utilizes Stanford-originated research to create innovative solutions.

Quick answer

Metabolize raised $3.2 Million in a Seed round, dated October 15, 2026. Investors: Sosv, LongGame Venture, Astanor and Maia Ventures. Metabolize is based in San Francisco, California, United States.

How much did Metabolize raise?
Metabolize raised $3.2 Million in a Seed round on October 15, 2026.
Who invested in Metabolize?
Sosv, LongGame Venture, Astanor and Maia Ventures are named as investors in this round.
What does Metabolize do?
Metabolize is a science-first consumer health company built on Stanford Medicine-originated research.
Where is Metabolize based and how big is it?
Metabolize is based in San Francisco, California, United States. Fundz records about 5 employees.
Who are the decision-makers at Metabolize?
Fundz holds 2 contacts at Metabolize, including the Founder & CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Metabolize that raised within 45 days of this round, from Fundz verified event records.

  • Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
  • Orakl Oncology raised $34M (Series A) on November 12, 2026.
  • Skribe Medical raised $1.6M (Pre-Seed) on November 12, 2026.
  • BioWraptor raised $1.5M (Pre-Seed) on November 12, 2026.
  • Neurosterix raised $105M (Series B) on November 11, 2026.
  • Kardi Ai raised $5.9M (Series A) on November 11, 2026.

Who to call at Metabolize, and when

A new round usually means Metabolize is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Metabolize raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Metabolize, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Metabolize. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Metabolize

Location

San Francisco, California, United States

About

Metabolize is a science-first consumer health company built on Stanford Medicine-originated research. It develops Precision Metabolite™ Technology based on naturally occurring compounds with defined biological roles. The company aims to translate these patent-protected discoveries into consumer metabolic health products. Its first product, NATLEAN, is designed to support individuals transitioning off GLP-1 therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Metabolize raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsMorris L., Founder & CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Metabolize's next move

See what Strategic adds

Metabolize raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.